Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 33
-3
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving Tropical Migratory Bird Habitat

    Migratory birds, songbirds in particular, over-winter in the tropics. Much of the land is being deforested...

    How do Aedes mosquito genetics affect their habitat choice?

    Mosquito habitat expansion has allowed for their reintroduction in the South. There is an increasing rate...

    Where are endangered California least terns spending their winters?

    Wintering habitats of California least terns remain unknown, despite having terns being listed as endangered...

    Backer Badge Funded